Phase 3 Revascularization Clinical Trials
2 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–2 of 2 trials
Recruiting
Phase 3
Improving Mobility After Revascularization in Peripheral Artery Disease
intermittent claudicationMobility LimitationPeripheral Artery Disease+2 more
Northwestern University386 enrolled7 locationsNCT06686121
Completed
Phase 3
"The LoDoCo2 Trial":Low Dose Colchicine for secondary prevention of cardiovascular disease.
Ischemia-driven coronary revascularizationCardiovascular deathIschemic Stroke
Heart Research Institute, Sir Charles Gairdner Hospital5,500 enrolled1 locationACTRN12614000093684